{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:39:47Z","timestamp":1792269587806,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T00:00:00Z","timestamp":1141776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/sj.npp.1301057","type":"journal-article","created":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T16:03:55Z","timestamp":1141833835000},"page":"719-727","source":"Crossref","is-referenced-by-count":110,"title":["Ketamine, at a Dose that Disrupts Motor Behavior and Latent Inhibition, Enhances Prefrontal Cortex Synaptic Efficacy and Glutamate Release in the Nucleus Accumbens"],"prefix":"10.1038","volume":"32","author":[{"given":"Florence","family":"Razoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"L\u00e9na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,8]]},"reference":[{"key":"BF1301057_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1176\/ajp.155.11.1550","volume":"155","author":"A Abi-Dargham","year":"1998","unstructured":"Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M et al (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatr 155: 761\u2013767.","journal-title":"Am J Psychiatr"},{"key":"BF1301057_CR2","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1523\/JNEUROSCI.18-14-05545.1998","volume":"18","author":"B Adams","year":"1998","unstructured":"Adams B, Moghaddam B (1998). Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18: 5545\u20135554.","journal-title":"J Neurosci"},{"key":"BF1301057_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0163-1047(05)80010-X","volume":"61","author":"L Aguado","year":"1994","unstructured":"Aguado L, San Antonio A, Perez L, del Valle R, Gomez J (1994). Effects of the NMDA receptor antagonist ketamine on flavor memory: conditioned aversion, latent inhibition, and habituation of neophobia. Behav Neural Biol 61: 271\u2013281.","journal-title":"Behav Neural Biol"},{"key":"BF1301057_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/archpsyc.1992.01820120031006","volume":"49","author":"NC Andreasen","year":"1992","unstructured":"Andreasen NC, Rezai K, Alliger R, Swayze II VW, Flaum M, Kirchner P et al (1992). Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatr 49: 943\u2013958.","journal-title":"Arch Gen Psychiatr"},{"key":"BF1301057_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0021-9673(96)00595-X","volume":"755","author":"L Bert","year":"1996","unstructured":"Bert L, Robert F, Denoroy L, Stoppini L, Renaud B (1996). Enhanced temporal resolution for the microdialysis monitoring of catecholamines and excitatory amino acids using capillary electrophoresis with laser-induced fluorescence detection. Analytical developments and in vitro validations. J Chromatogr A 755: 99\u2013111.","journal-title":"J Chromatogr A"},{"key":"BF1301057_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/archpsyc.1985.01790310046006","volume":"42","author":"B Bogerts","year":"1985","unstructured":"Bogerts B, Meertz E, Schonfeldt-Bausch R (1985). Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatr 42: 784\u2013791.","journal-title":"Arch Gen Psychiatr"},{"key":"BF1301057_CR7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.4178-03.2004","volume":"24","author":"AM Brady","year":"2004","unstructured":"Brady AM, O'Donnell P (2004). Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo. J Neurosci 24: 1040\u20131049.","journal-title":"J Neurosci"},{"key":"BF1301057_CR8","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","volume":"94","author":"A Breier","year":"1997","unstructured":"Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A et al (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci 94: 2569\u20132574.","journal-title":"Proc Natl Acad Sci"},{"key":"BF1301057_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0091-3057(90)90285-P","volume":"35","author":"ER Butelman","year":"1990","unstructured":"Butelman ER (1990). The effect of NMDA antagonists in the radial arm maze task with an interposed delay. Pharmacol Biochem Behav 35: 533\u2013536.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301057_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1176\/appi.ajp.160.12.2209","volume":"160","author":"JH Callicott","year":"2003","unstructured":"Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR (2003). Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatr 160: 2209\u20132215.","journal-title":"Am J Psychiatr"},{"key":"BF1301057_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0006-3223(99)00117-1","volume":"46","author":"A Carlsson","year":"1999","unstructured":"Carlsson A, Waters N, Carlsson ML (1999). Neurotransmitter interactions in schizophrenia-therapeutic implications. Biol Psychiatr 46: 1388\u20131395.","journal-title":"Biol Psychiatr"},{"key":"BF1301057_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-3565(24)35084-0","volume":"291","author":"J Cartmell","year":"1999","unstructured":"Cartmell J, Monn JA, Schoepp DD (1999). The metabotropic glutamate 2\/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291: 161\u2013170.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301057_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1196\/annals.1300.020","volume":"1003","author":"JT Coyle","year":"2003","unstructured":"Coyle JT, Tsai G, Goff D (2003). Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann NY Acad Sci 1003: 318\u2013327.","journal-title":"Ann NY Acad Sci"},{"key":"BF1301057_CR14","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1073\/pnas.95.19.11406","volume":"95","author":"JG Csernansky","year":"1998","unstructured":"Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP et al (1998). Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci 95: 11406\u201311411.","journal-title":"Proc Natl Acad Sci"},{"key":"BF1301057_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(SICI)1098-2396(199610)24:2<135::AID-SYN5>3.0.CO;2-G","volume":"24","author":"JP Druhan","year":"1996","unstructured":"Druhan JP, Rajabi H, Stewart J (1996). MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse 24: 135\u2013146.","journal-title":"Synapse"},{"key":"BF1301057_CR16","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1523\/JNEUROSCI.21-08-02851.2001","volume":"21","author":"SB Floresco","year":"2001","unstructured":"Floresco SB, Blaha CD, Yang CR, Phillips AG (2001). Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection. J Neurosci 21: 2851\u20132860.","journal-title":"J Neurosci"},{"key":"BF1301057_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00213-002-1311-z","volume":"166","author":"I Gaisler-Salomon","year":"2003","unstructured":"Gaisler-Salomon I, Weiner I (2003). Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology 166: 333\u2013342.","journal-title":"Psychopharmacology"},{"key":"BF1301057_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","volume":"57","author":"LA Glantz","year":"2000","unstructured":"Glantz LA, Lewis DA (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatr 57: 65\u201373.","journal-title":"Arch Gen Psychiatr"},{"key":"BF1301057_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuron.2005.06.017","volume":"47","author":"Y Goto","year":"2005","unstructured":"Goto Y, Grace AA (2005a). Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization. Neuron 47: 255\u2013266.","journal-title":"Neuron"},{"key":"BF1301057_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nn1471","volume":"8","author":"Y Goto","year":"2005","unstructured":"Goto Y, Grace AA (2005b). Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 8: 805\u2013812.","journal-title":"Nat Neurosci"},{"key":"BF1301057_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","volume":"4","author":"AA Grace","year":"1991","unstructured":"Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 4: 1\u201324.","journal-title":"Neuroscience"},{"key":"BF1301057_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0165-0173(99)00049-1","volume":"31","author":"AA Grace","year":"2000","unstructured":"Grace AA (2000). Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 31: 330\u2013341.","journal-title":"Brain Res Rev"},{"key":"BF1301057_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/1137","volume":"1","author":"S Heckers","year":"1998","unstructured":"Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fischman AJ et al (1998). Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1: 318\u2013323.","journal-title":"Nat Neurosci"},{"key":"BF1301057_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1523\/JNEUROSCI.3800-04.2005","volume":"25","author":"MJ Hunt","year":"2005","unstructured":"Hunt MJ, Kessal K, Garcia R (2005). Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats. J Neurosci 25: 524\u2013531.","journal-title":"J Neurosci"},{"key":"BF1301057_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0091-3057(94)00379-W","volume":"51","author":"M Irifune","year":"1995","unstructured":"Irifune M, Shimizu T, Nomoto M, Fukuda T (1995). Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacol Biochem Behav 51: 291\u2013296.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301057_CR26","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.1073\/pnas.0308455101","volume":"101","author":"ME Jackson","year":"2004","unstructured":"Jackson ME, Homayoun H, Moghaddam B (2004). NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci 101: 8467\u20138472.","journal-title":"Proc Natl Acad Sci"},{"key":"BF1301057_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatr 148: 1301\u20131308.","journal-title":"Am J Psychiatr"},{"key":"BF1301057_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20: 201\u2013225.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301057_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0091-3057(93)90484-B","volume":"44","author":"RP Kesner","year":"1993","unstructured":"Kesner RP, Dakis M (1993). Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task. Pharmacol Biochem Behav 44: 419\u2013424.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301057_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/syn.20154","volume":"57","author":"K Kessal","year":"2005","unstructured":"Kessal K, Chessel A, Spennato G, Garcia R (2005). Ketamine and amphetamine both enhance synaptic transmission in the amygdala-nucleus accumbens pathway but with different time-courses. Synapse 57: 61\u201365.","journal-title":"Synapse"},{"key":"BF1301057_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatr 51: 199\u2013214.","journal-title":"Arch Gen Psychiatr"},{"key":"BF1301057_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","volume":"13","author":"AC Lahti","year":"1995","unstructured":"Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9\u201319.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301057_CR33","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J et al (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci 93: 9235\u20139240.","journal-title":"Proc Natl Acad Sci"},{"key":"BF1301057_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","volume":"117","author":"DS Lorrain","year":"2003","unstructured":"Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003). Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117: 697\u2013706.","journal-title":"Neuroscience"},{"key":"BF1301057_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/A:1026613928155","volume":"31","author":"LV Loskutova","year":"2001","unstructured":"Loskutova LV (2001). The effects of a serotoninergic substrate of the nucleus accumbens on latent inhibition. Neurosci Behav Physiol 31: 15\u201320.","journal-title":"Neurosci Behav Physiol"},{"key":"BF1301057_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","volume":"81","author":"ED Luby","year":"1959","unstructured":"Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959). Study of a new schizophrenomimetic drug; sernyl. Arch Neurol Psychiatr 81: 363\u2013369.","journal-title":"Arch Neurol Psychiatr"},{"key":"BF1301057_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","volume":"17","author":"AK Malhotra","year":"1997","unstructured":"Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17: 141\u2013150.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301057_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","volume":"14","author":"AK Malhotra","year":"1996","unstructured":"Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D et al (1996). NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14: 301\u2013307.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301057_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0920-9964(02)00294-3","volume":"60","author":"DS Manoach","year":"2003","unstructured":"Manoach DS (2003). Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res 60: 285\u2013298.","journal-title":"Schizophr Res"},{"key":"BF1301057_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0301-0082(80)90018-0","volume":"14","author":"GJ Mogenson","year":"1980","unstructured":"Mogenson GJ, Jones DL, Yim CY (1980). From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14: 69\u201397.","journal-title":"Prog Neurobiol"},{"key":"BF1301057_CR41","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921\u20132927.","journal-title":"J Neurosci"},{"key":"BF1301057_CR42","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","volume":"281","author":"B Moghaddam","year":"1998","unstructured":"Moghaddam B, Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349\u20131352.","journal-title":"Science"},{"key":"BF1301057_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0165-0173(00)00026-6","volume":"33","author":"PC Moser","year":"2000","unstructured":"Moser PC, Hitchcock JM, Lister S, Moran PM (2000). The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Rev 33: 275\u2013307.","journal-title":"Brain Res Rev"},{"key":"BF1301057_CR44","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","volume":"52","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB (1995). Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatr 52: 998\u20131007.","journal-title":"Arch Gen Psychiatr"},{"key":"BF1301057_CR45","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York."},{"key":"BF1301057_CR46","first-page":"3","volume":"7","author":"F Sams-Dodd","year":"1996","unstructured":"Sams-Dodd F (1996). Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol 7: 3\u201323.","journal-title":"Behav Pharmacol"},{"key":"BF1301057_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0006-8993(90)91146-8","volume":"527","author":"SR Sesack","year":"1990","unstructured":"Sesack SR, Pickel VM (1990). In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527: 266\u2013279.","journal-title":"Brain Res"},{"key":"BF1301057_CR48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1192\/bjp.172.4.316","volume":"172","author":"SA Spence","year":"1998","unstructured":"Spence SA, Hirsch SR, Brooks DJ, Grasby PM (1998). Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of \u2018hypofrontality\u2019 with recovery from acute schizophrenia. Br J Psychiatr 172: 316\u2013323.","journal-title":"Br J Psychiatr"},{"key":"BF1301057_CR49","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/sj.npp.1300127","volume":"28","author":"R Takahata","year":"2003","unstructured":"Takahata R, Moghaddam B (2003). Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 28: 1117\u20131124.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301057_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1074-7427(03)00059-5","volume":"80","author":"LM Traverso","year":"2003","unstructured":"Traverso LM, Ruiz G, De la Casa LG (2003). Latent inhibition disruption by MK-801 in a conditioned taste-aversion paradigm. Neurobiol Learn Mem 80: 140\u2013146.","journal-title":"Neurobiol Learn Mem"},{"key":"BF1301057_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0091-3057(00)00223-9","volume":"66","author":"SM Turgeon","year":"2000","unstructured":"Turgeon SM, Auerbach EA, Duncan-Smith MK, George JR, Graves WW (2000). The delayed effects of DTG and MK-801 on latent inhibition in a conditioned taste-aversion paradigm. Pharmacol Biochem Behav 66: 533\u2013539.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1301057_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1523\/JNEUROSCI.16-01-00373.1996","volume":"16","author":"A Verma","year":"1996","unstructured":"Verma A, Moghaddam B (1996). NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16: 373\u2013379.","journal-title":"J Neurosci"},{"key":"BF1301057_CR53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/archpsyc.1986.01800020020004","volume":"43","author":"DR Weinberger","year":"1986","unstructured":"Weinberger DR, Berman KF, Zec RF (1986). Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatr 43: 114\u2013124.","journal-title":"Arch Gen Psychiatr"},{"key":"BF1301057_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00213-002-1313-x","volume":"169","author":"I Weiner","year":"2003","unstructured":"Weiner I (2003). The \u2018two-headed\u2019 latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169: 257\u2013297.","journal-title":"Psychopharmacology"},{"key":"BF1301057_CR55","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/0306-4522(92)90202-D","volume":"50","author":"DS Zahm","year":"1992","unstructured":"Zahm DS, Brog JS (1992). On the significance of subterritories in the \u2018accumbens\u2019 part of the rat ventral striatum. Neuroscience 50: 751\u2013767.","journal-title":"Neuroscience"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301057","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T23:26:56Z","timestamp":1736292416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,8]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF1301057"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301057","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,8]]}}}